AstraZeneca receives approval to market cancer drug Tagrisso in China
British pharmaceutical firm AstraZeneca has received regulatory approval in China to market Tagrisso as a...
Read More...
Focus:
China
-
![]()
HIV mortality in China is increasing faster for men than women
Human immunodeficiency virus (HIV) remains a major epidemic in China. GlobalData’s epidemiology report on HIV...
Read More...
-
![]()
China approves Gilead’s HIV-1 drug candidate Biktarvy
The China National Medical Products Administration (NMPA) has approved Gilead Sciences’ Biktarvy, a once-daily single-tablet...
Read More...
-
![]()
Innovent and Shenogen study Tyvyt-SNG1005 combination for cancer
Innovent Biologics and Shenogen Pharma Group have signed a collaboration agreement to evaluate the combination...
Read More...
-
![]()
Eisai’s New Oral Solid Dose Production Facility, Suzhou
Eisai China has built a new oral solid dose (OSD) production facility at its new...
Read More...
-
![GenScript Biologics Manufacturing Centre]()
GenScript’s Biologics Manufacturing Centre, Zhenjiang
GenScript Biotech is constructing a biologics manufacturing centre in Zhenjiang city, Jiangsu Province, China.
Read More...
-
![Bladder cancer treatment]()
Beigene’s Tislelizumab receives second priority review by China’s NMPA
The incidence of bladder cancer is ranked sixth by the National Central Cancer Registry (NCCR)...
Read More...
-
![US-China pharma trade]()
US-China trade war casualties: Biopharma sees the first wave of CFIUS vetoes, but no tariffs on Chinese pharma imports
Elsewhere in the US-China trade war, the Office of the US Trade Representative has said...
Read More...
-
![dry eye disease]()
Sun Pharma and CMS to commercialise CsA eye drops in China
A subsidiary of Sun Pharmaceutical Industries has signed an agreement with a China Medical System...
Read More...
-
Terns to commercialise GENFIT’s elafibranor to treat NASH and PBC
Terns Pharmaceuticals has signed an agreement to acquire the exclusive rights to develop, register and...
Read More...